Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 10
2004 4
2005 11
2006 4
2007 8
2008 4
2009 5
2010 4
2011 7
2012 7
2013 4
2014 4
2015 9
2016 2
2017 3
2018 2
2019 2
2020 1
2021 5
2022 4
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Improved recognition of lung function decline as signal of cystic fibrosis pulmonary exacerbation: a Cystic Fibrosis Learning Network Innovation Laboratory quality improvement initiative.
List R, Solomon G, Bichl S, Horton BJ, Shen S, Corcoran B, Sadeghi H, Britto MT, Ren C, Albon D; CFLN Collaboration Group FIES/SIES Innovation Lab. List R, et al. BMJ Open Qual. 2023 Dec 28;12(4):e002466. doi: 10.1136/bmjoq-2023-002466. BMJ Open Qual. 2023. PMID: 38154821 Free PMC article.
Establishing a Cystic Fibrosis Learning Network: Interventions to promote collaboration and data-driven improvement at scale.
Ong T, Albon D, Amin RS, Bailey J, Bandla S, Britto MT, Flath J, Gamel B, Powers M, Sabadosa KA, Saulitis AK, Thomas LK, Thurmond S, Seid M; Cystic Fibrosis Learning Network. Ong T, et al. Among authors: powers m. Learn Health Syst. 2022 Dec 19;7(3):e10354. doi: 10.1002/lrh2.10354. eCollection 2023 Jul. Learn Health Syst. 2022. PMID: 37448461 Free PMC article.
The US national registry for childhood interstitial and diffuse lung disease: Report of study design and initial enrollment cohort.
Nevel RJ, Deutsch GH, Craven D, Deterding R, Fishman MP, Wambach JA, Casey A, Krone K, Liptzin DR, O'Connor MG, Kurland G, Taylor JB, Gower WA, Hagood JS, Conrad C, Tam-Williams JB, Fiorino EK, Goldfarb S, Sadreameli SC, Nogee LM, Montgomery G, Hamvas A, Laguna TA, Bansal M, Lew C, Santiago M, Popova A, De A, Chan M, Powers MR, Josephson MB, Camburn D, Voss L, Li Y, Young LR; chILD Registry Collaborative. Nevel RJ, et al. Among authors: powers mr. Pediatr Pulmonol. 2023 Jul 4:10.1002/ppul.26568. doi: 10.1002/ppul.26568. Online ahead of print. Pediatr Pulmonol. 2023. PMID: 37401889
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged ⩾6 Years with Cystic Fibrosis and at Least One F508del Allele: A Phase 3, Open-Label Clinical Trial.
Wainwright C, McColley SA, McNally P, Powers M, Ratjen F, Rayment JH, Retsch-Bogart G, Roesch E, Ahluwalia N, Chin A, Chu C, Lu M, Menon P, Waltz D, Weinstock T, Zelazoski L, Davies JC. Wainwright C, et al. Among authors: powers m. Am J Respir Crit Care Med. 2023 Jul 1;208(1):68-78. doi: 10.1164/rccm.202301-0021OC. Am J Respir Crit Care Med. 2023. PMID: 37154609
The effect of inhaled hypertonic saline on lung structure in children aged 3-6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial.
Tiddens HAWM, Chen Y, Andrinopoulou ER, Davis SD, Rosenfeld M, Ratjen F, Kronmal RA, Hinckley Stukovsky KD, Dasiewicz A, Stick SM; SHIP-CT Study Group. Tiddens HAWM, et al. Lancet Respir Med. 2022 Jul;10(7):669-678. doi: 10.1016/S2213-2600(21)00546-4. Epub 2022 Mar 11. Lancet Respir Med. 2022. PMID: 35286860 Clinical Trial.
101 results